Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $96.3600 (-1%) ($93.9900 - $98.8000) on Tue. Apr. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.07% (three month average) | RSI | 79 | Latest Price | $96.3600(-1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.1% a day on average for past five trading days. | Weekly Trend | LGND advances 12.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(51%) IWC(48%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -3.035% in a week (0% probabilities). VIXM(-25%) UUP(-17%) VXX(-16%) UNG(-2%) TLT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.035% (StdDev 6.07%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
5 Day Moving Average | $92.93(3.69%) | 10 Day Moving Average | $89.67(7.46%) | 20 Day Moving Average | $81.18(18.7%) | To recent high | -10.7% | To recent low | 52.1% | Market Cap | $1.549b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |